‘DIVOC Labs’ – First Telemedicine diagnosis lab launched in India. Introducing Labs of the future – diagnostics test and results at home with accuracy in less than 20 minutes. Patients find home healthcare more efficient because it provides contact less treatment and diagnostics results.
New Delhi, 29th August 2020: With a mission to create the most advanced digital diagnostic laboratory network enabling the connected world and to provide telemedicine and instant care, DIVOC Health launched its first, one-of-a-kind, technologically advanced DIVOC Laboratories in New Delhi. Through the new-age labs of the future, it facilitates patients to have a lab at the comfort of their homes.
It has also introduced at-home, instant diagnostics which would allow phlebotomists to conduct testing and deliver results right away. The ‘lab of the future’ has collaborated with United Kingdom laboratories to bring 21st century innovations into diagnostics. With faster results i.e within 20 minutes at home, DIVOC is also empowering and enabling the overall telemedicine segment in India. This innovation will enable a new generation of medicine where the operations can extend into peoples’ homes and the diagnostic continuum can empower a truly connected, omnipresent vision of health.
DIVOC Laboratories offer more than 500 tests including Clinical Chemistry, Clinical Microbiology, Hematology, Serology, Clinical Microscopy, Cytopathology and Molecular Biology. It also offers TRUNAAT, RT PCR and Antigen COVID Testing pending ICMR notifications and approvals.
DIVOC Laboratories has setup a state of the art facility in Okhla, New Delhi which can enable a variety of testing. The lab is formed by leading global health experts and practitioners, envisions enabling a digitally empowered integrated approach to diagnostics. Facilitating people with telemedicine, the lab of the future will provide Instant Home Kit, Drug Delivery and also, work with existing aggregators to provide Doctors. To bring the latest innovations, advanced concepts and technology for the benefit of clinics and patients, the Divoc labs focuses on Validation, Knowledge Management, New Technology Evaluation, New Assay Development, R&D and Contract Research.
DIVOC Health is formed to reverse the COVID-19 pandemic. Using innovative approaches and products, DIVOC envisions addressing the needs of the Indian healthcare sector. It is established by Dr Kanav Kahol, a renowned healthcare innovator who is a former PhD scientist and professor from Arizona State University and Mayo Clinic USA in partnership with Christopher Egerton Warburton (Edge) form Lions Global Head Partners UK. DIVOC Health is striving to address the immediate need of the country to have access to high quality COVID-19 tests. DIVOC is also working on healthcare delivery models to enable quality healthcare through technology.
Speaking on the occasion, Dr. Kanav Kahol said, “We aim to provide a modern, quality driven digital approach to laboratory operations that facilitate consumers with unprecedented reliability, convenience, and impactful innovations. We promise to be digitally empowered, bring innovations to improve health and be trustworthy and responsible for our operations. For telemedicine to be successful it is important to have equally faster diagnostics at the doorstep, just as instant as virtual health consultations are. We have plans to establish 20 of Divoc Labs in India within this year”
